In a significant development for healthcare access, the Ayushman Bharat Yojana will now cover the treatment of thalassemia patients with an allocation of up to ₹14 lakh. This generous provision aims to make life-saving treatments more attainable for individuals diagnosed with this genetic blood disorder. Thalassemia necessitates ongoing medical management, including regular blood transfusions and medication, which can be financially draining. By integrating these comprehensive treatment costs into the Ayushman scheme, the government is reinforcing its dedication to universal healthcare. This policy adjustment is poised to benefit a large number of patients and their families, offering a much-needed financial safety net. The enhanced scope of the Ayushman Yojana reflects a commitment to addressing serious health conditions and improving the quality of life for those affected.
